P&G Gains European OTC Allergy Presence With Grupo Vita Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble's purchase of Spanish pharmaceutical company Grupo Vita's commercial business gives the firm access to the non-sedating antihistamine loratadine
You may also be interested in...
Does A Procter & Gamble-Aventis Merger Make Cents?
A combination between Procter & Gamble and France's largest drug maker, Aventis, would give P&G an immediate play into the prescription drug arena while simultaneously bolstering the firm's Rx-to-OTC switch pipeline with potential blockbuster candidates
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands